TY - JOUR AU - Bourin, P. AU - Gadelorge, M. AU - Peyrafitte, J. -. A. AU - Fleury-Cappellesso, S. AU - Gomez, M. AU - Rage, C. PY - 2008 DA - 2008// TI - Mesenchymal progenitor cells: tissue origin, isolation and culture JO - Transfus Med Hemother VL - 35 UR - https://doi.org/10.1159/000124734 DO - 10.1159/000124734 ID - Bourin2008 ER - TY - JOUR AU - Conget, P. A. AU - Minguell, J. J. PY - 1999 DA - 1999// TI - Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells JO - J Cell Physiol VL - 181 UR - https://doi.org/3.0.CO;2-C DO - 3.0.CO;2-C ID - Conget1999 ER - TY - JOUR AU - Rasmusson, I. PY - 2006 DA - 2006// TI - Immune modulation by mesenchymal stem cells JO - Exp Cell Res VL - 312 UR - https://doi.org/10.1016/j.yexcr.2006.03.019 DO - 10.1016/j.yexcr.2006.03.019 ID - Rasmusson2006 ER - TY - JOUR AU - Ezquer, F. AU - Ezquer, M. AU - Simon, V. AU - Pardo, F. AU - Yañez, A. AU - Carpio, D. PY - 2009 DA - 2009// TI - Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice JO - Biol Blood Marrow Transplant VL - 15 UR - https://doi.org/10.1016/j.bbmt.2009.07.022 DO - 10.1016/j.bbmt.2009.07.022 ID - Ezquer2009 ER - TY - JOUR AU - Hagenhoff, A. AU - Bruns, C. J. AU - Zhao, Y. AU - von Lüttichau, I. AU - Niess, H. AU - Spitzweg, C. PY - 2016 DA - 2016// TI - Harnessing mesenchymal stem cell homing as an anticancer therapy JO - Expert Opin Biol Ther VL - 16 UR - https://doi.org/10.1080/14712598.2016.1196179 DO - 10.1080/14712598.2016.1196179 ID - Hagenhoff2016 ER - TY - JOUR AU - Ezquer, M. AU - Ezquer, F. AU - Ricca, M. AU - Allers, C. AU - Conget, P. PY - 2011 DA - 2011// TI - Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome JO - J Hepatol VL - 55 UR - https://doi.org/10.1016/j.jhep.2011.02.020 DO - 10.1016/j.jhep.2011.02.020 ID - Ezquer2011 ER - TY - JOUR AU - Caplan, A. I. AU - Dennis, J. E. PY - 2006 DA - 2006// TI - Mesenchymal stem cells as trophic mediators JO - J Cell Biochem VL - 98 UR - https://doi.org/10.1002/jcb.20886 DO - 10.1002/jcb.20886 ID - Caplan2006 ER - TY - JOUR AU - Ball, S. G. AU - Shuttleworth, C. A. AU - Kielty, C. M. PY - 2007 DA - 2007// TI - Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors JO - J Cell Mol Med VL - 11 UR - https://doi.org/10.1111/j.1582-4934.2007.00120.x DO - 10.1111/j.1582-4934.2007.00120.x ID - Ball2007 ER - TY - JOUR AU - Valle-Prieto, A. AU - Conget, P. A. PY - 2010 DA - 2010// TI - Human mesenchymal stem cells efficiently manage oxidative stress JO - Stem Cells Dev VL - 19 UR - https://doi.org/10.1089/scd.2010.0093 DO - 10.1089/scd.2010.0093 ID - Valle-Prieto2010 ER - TY - JOUR AU - Morando, S. AU - Vigo, T. AU - Esposito, M. AU - Casazza, S. AU - Novi, G. AU - Principato, M. PY - 2012 DA - 2012// TI - The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms JO - Stem Cell Res Ther VL - 3 UR - https://doi.org/10.1186/scrt94 DO - 10.1186/scrt94 ID - Morando2012 ER - TY - JOUR AU - Taylor, P. L. AU - Barker, R. A. AU - Blume, K. G. AU - Cattaneo, E. AU - Colman, A. AU - Deng, H. PY - 2010 DA - 2010// TI - Patients beware: commercialized stem cell treatments on the web JO - Cell Stem Cell VL - 7 UR - https://doi.org/10.1016/j.stem.2010.06.001 DO - 10.1016/j.stem.2010.06.001 ID - Taylor2010 ER - TY - JOUR AU - Volarevic, V. AU - Markovic, B. S. AU - Gazdic, M. AU - Volarevic, A. AU - Jovicic, N. AU - Arsenijevic, N. PY - 2018 DA - 2018// TI - Ethical and safety issues of stem cell-based therapy JO - Int J Med Sci VL - 15 UR - https://doi.org/10.7150/ijms.21666 DO - 10.7150/ijms.21666 ID - Volarevic2018 ER - TY - JOUR AU - Prockop, D. J. AU - Brenner, M. AU - Fibbe, W. E. AU - Horwitz, E. AU - Le Blanc, K. AU - Phinney, D. G. PY - 2010 DA - 2010// TI - Defining the risks of mesenchymal stromal cell therapy JO - Cytotherapy VL - 12 UR - https://doi.org/10.3109/14653249.2010.507330 DO - 10.3109/14653249.2010.507330 ID - Prockop2010 ER - TY - JOUR AU - Arango-Rodriguez, M. L. AU - Ezquer, F. AU - Ezquer, M. AU - Conget, P. PY - 2015 DA - 2015// TI - Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? JO - World J Stem Cells VL - 7 UR - https://doi.org/10.4252/wjsc.v7.i2.408 DO - 10.4252/wjsc.v7.i2.408 ID - Arango-Rodriguez2015 ER - TY - JOUR AU - Lalu, M. M. AU - McIntyre, L. AU - Pugliese, C. AU - Fergusson, D. AU - Winston, B. W. AU - Marshall, J. C. PY - 2012 DA - 2012// TI - Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0047559 DO - 10.1371/journal.pone.0047559 ID - Lalu2012 ER - TY - JOUR AU - Klopp, A. H. AU - Gupta, A. AU - Spaeth, E. AU - Andreeff, M. AU - Marini, F. PY - 2011 DA - 2011// TI - Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? JO - Stem Cells VL - 29 UR - https://doi.org/10.1002/stem.559 DO - 10.1002/stem.559 ID - Klopp2011 ER - TY - JOUR AU - Young, M. R. I. PY - 2017 DA - 2017// TI - Redirecting the focus of cancer immunotherapy to premalignant conditions JO - Cancer Lett VL - 391 UR - https://doi.org/10.1016/j.canlet.2017.01.022 DO - 10.1016/j.canlet.2017.01.022 ID - Young2017 ER - TY - JOUR AU - Schwartz, J. AU - Shklar, G. AU - Reid, S. AU - Trickier, D. PY - 1988 DA - 1988// TI - Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae JO - Nutr Cancer VL - 11 UR - https://doi.org/10.1080/01635588809513979 DO - 10.1080/01635588809513979 ID - Schwartz1988 ER - TY - JOUR AU - Bruna, F. AU - Arango-Rodríguez, M. AU - Plaza, A. AU - Espinoza, I. AU - Conget, P. PY - 2017 DA - 2017// TI - The administration of multipotent stromal cells at precancerous stage precludes tumor growth and epithelial dedifferentiation of oral squamous cell carcinoma JO - Stem Cell Res VL - 18 UR - https://doi.org/10.1016/j.scr.2016.11.016 DO - 10.1016/j.scr.2016.11.016 ID - Bruna2017 ER - TY - JOUR AU - Contador, D. AU - Ezquer, F. AU - Espinosa, M. AU - Arango-Rodriguez, M. AU - Puebla, C. AU - Sobrevia, L. PY - 2015 DA - 2015// TI - Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells JO - Exp Biol Med VL - 240 UR - https://doi.org/10.1177/1535370214566565 DO - 10.1177/1535370214566565 ID - Contador2015 ER - TY - JOUR AU - Cavalieri, E. L. AU - Rogan, E. G. PY - 1992 DA - 1992// TI - The approach to understanding aromatic hydrocarbon carcinogenesis. The central role of radical cations in metabolic activation JO - Pharmacol Ther VL - 55 UR - https://doi.org/10.1016/0163-7258(92)90015-R DO - 10.1016/0163-7258(92)90015-R ID - Cavalieri1992 ER - TY - JOUR AU - Suzuki, K. AU - Sun, R. AU - Origuchi, M. AU - Kanehira, M. AU - Takahata, T. AU - Itoh, J. PY - 2011 DA - 2011// TI - Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization JO - Mol Med VL - 17 UR - https://doi.org/10.2119/molmed.2010.00157 DO - 10.2119/molmed.2010.00157 ID - Suzuki2011 ER - TY - JOUR AU - Xia, L. AU - Peng, R. AU - Leng, W. AU - Jia, R. AU - Zeng, X. AU - Yang, X. PY - 2015 DA - 2015// TI - TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma JO - J Dent Res VL - 94 UR - https://doi.org/10.1177/0022034514557815 DO - 10.1177/0022034514557815 ID - Xia2015 ER - TY - JOUR AU - Sage, E. K. AU - Kolluri, K. K. AU - McNulty, K. AU - Lourenco, S. D. S. AU - Kalber, T. L. AU - Ordidge, K. L. PY - 2014 DA - 2014// TI - Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma JO - Thorax VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2013-204110 DO - 10.1136/thoraxjnl-2013-204110 ID - Sage2014 ER - TY - JOUR AU - Visvader, J. E. AU - Lindeman, G. J. PY - 2008 DA - 2008// TI - Cancer stem cells in solid tumours: accumulating evidence and unresolved questions JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2499 DO - 10.1038/nrc2499 ID - Visvader2008 ER - TY - JOUR AU - Hegarty, A. M. AU - Hunter, K. D. PY - 2016 DA - 2016// TI - Oral malignancy and premalignancy JO - Br J Hosp Med VL - 77 UR - https://doi.org/10.12968/hmed.2016.77.4.232 DO - 10.12968/hmed.2016.77.4.232 ID - Hegarty2016 ER - TY - JOUR AU - Byun, J. S. AU - Gardner, K. PY - 2013 DA - 2013// TI - Wounds that will not heal: pervasive cellular reprogramming in cancer JO - Am J Pathol VL - 182 UR - https://doi.org/10.1016/j.ajpath.2013.01.009 DO - 10.1016/j.ajpath.2013.01.009 ID - Byun2013 ER - TY - JOUR AU - Spaeth, E. AU - Klopp, A. AU - Dembinski, J. AU - Andreeff, M. AU - Marini, F. PY - 2008 DA - 2008// TI - Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells JO - Gene Ther VL - 15 UR - https://doi.org/10.1038/gt.2008.39 DO - 10.1038/gt.2008.39 ID - Spaeth2008 ER - TY - JOUR AU - Hamamoto, H. AU - Gorman, J. H. AU - Ryan, L. P. AU - Hinmon, R. AU - Martens, T. P. AU - Schuster, M. D. PY - 2009 DA - 2009// TI - Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage JO - Ann Thorac Surg VL - 87 UR - https://doi.org/10.1016/j.athoracsur.2008.11.057 DO - 10.1016/j.athoracsur.2008.11.057 ID - Hamamoto2009 ER - TY - JOUR AU - Hare, J. M. AU - Fishman, J. E. AU - Gerstenblith, G. AU - DiFede Velazquez, D. L. AU - Zambrano, J. P. AU - Suncion, V. Y. PY - 2012 DA - 2012// TI - Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy JO - JAMA VL - 308 UR - https://doi.org/10.1001/jama.2012.25321 DO - 10.1001/jama.2012.25321 ID - Hare2012 ER - TY - JOUR AU - Grégoire, C. AU - Lechanteur, C. AU - Briquet, A. AU - Baudoux, É. AU - Baron, F. AU - Louis, E. PY - 2017 DA - 2017// TI - Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases JO - Aliment Pharmacol Ther VL - 45 UR - https://doi.org/10.1111/apt.13864 DO - 10.1111/apt.13864 ID - Grégoire2017 ER - TY - JOUR AU - Djouad, F. AU - Bony, C. AU - Apparailly, F. AU - Louis-Plence, P. AU - Jorgense, C. AU - Noel, D. PY - 2006 DA - 2006// TI - Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells JO - Transplantation VL - 82 UR - https://doi.org/10.1097/01.tp.0000236098.13804.0b DO - 10.1097/01.tp.0000236098.13804.0b ID - Djouad2006 ER - TY - JOUR AU - Ezquer, F. AU - Ezquer, M. AU - Contador, D. AU - Ricca, M. AU - Simon, V. AU - Conget, P. PY - 2012 DA - 2012// TI - The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment JO - Stem Cells VL - 30 UR - https://doi.org/10.1002/stem.1132 DO - 10.1002/stem.1132 ID - Ezquer2012 ER -